The second part of our newly erected facility was purpose
built for the production of bulk drugs, where each product has a
segregated production, processing and packaging area.
Every care is taken at each stage to maintain the product quality
and yield, again via our four stage testing process:
1. Raw Material testing and approval
2. Validation of production machinery
3. In process testing
4. Final product analysis
Each product has a dedicated team, which aids in the improvement
of our processes and products, and is a measure of our intention
to provide the right quality material in time for our client's deadlines.
Within our bulk drug unit, the core competence and focus is on the
production of antibiotics.
At Dalas Biotech we are focused on improving all aspects
of the products that we manufacture, often with the result that
our specifications exceed those that are provided by international
Our current product range includes the following:
Great care is taken to prevent any chance of cross contamination,
to the extent that each product once entered into the production
cycle, is completely separated from any other product. We implement
this system by segregating the following:
1. Production vessels
3. Drying Areas
4. Packing Areas
The quality control department is involved at every stage, and no
material is able to leave our facility unless approved, and according
to the standards specified.
Annual capacities are variable on a product-by-product basis with
maximum capacities approaching the 250 Tonnes per annum mark. Further
technical details can be found on our specifications page.
Should you have any enquiries, please feel free to contact a member
of our team at email@example.com